Detection Of Residual Disease And Recurrence In Early-Stage Non-Small Cell Lung Cancer (Nsclc) Patients Using Sensitive Personalized Ctdna Sequencing Assays.

Katrin Heider,Davina Gillian Gale,Giovanni Marsico,Andrea Ruiz-Valdepeñas,Garima Sharma,Malcolm Perry,Robert Osborne,Karen Howarth,Viona Rundell,Jelena Belic,Jerome Wulff,Susan Harden,Doris M Rassl,Robert Rintoul,Nitzan Rosenfeld

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 3|浏览10

暂无评分

摘要

e15560Background: Detection of residual circulating tumour DNA (ctDNA) in patient plasma following curative intervention for localized non-small cell lung cancer (NSCLC) could identify patients who...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要